- U.S. Patent and Trademark Office Allows Non-Invasive Blood Glucose Monitoring Patent to Novanex Inc. [Jan. 15, 2014]
- List of Publications, Novanex Inc. [Jan. 15, 2014]
Novanex is a US-based medical device company that develops and commercializes innovative device and technology to monitor or detect disease conditions or status. Our first developmental product, OMC100, monitors and displays the blood glucose level non-invasively in two minutes. The system is designed for use in hospitals as well as in outpatient sites and homes. OMC 100 is in the process of US regulatory filing, and has been tested in with high reliability and accuracy in several studies. Results indicate performance similar to those of invasive glucose sensors on the market today. The Company's products are based on its proprietary, patent-pending Optimized Metabolic Calorimetry (OMC) technology, which overcomes critical obstacles that hinder the performance of many competing approaches/technologies. Novanex has filed US patent application to protect its novel device, method, and algorithm.